Ontology type: schema:ScholarlyArticle Open Access: True
2000-11-14
AUTHORSF Carozzi, G Ronco, M Confortini, D Noferini, C Maddau, S Ciatto, N Segnan
ABSTRACTHuman papillomavirus (HPV) testing has been suggested for primary screening of cervical cancer. Prediction of future high-grade cervical lesions is crucial for effectiveness and cost. We performed a case control study in a retrospective cohort of women with at least two cervical smears, all but the last one being negative, from the organized cervical screening programme in Florence, Italy. We searched for high-risk HPV in all previous, archival, smears from cases (new histologically confirmed cervical intraepithelial neoplasia (CIN) grade II or worse) and in one previous smear from each control (last smear cytologically normal, matched by age and interval (latency) from last smear). We applied polymerase chain reaction (PCR), and the b-globin gene was used as a DNA preservation marker. High-risk HPV was identified in 71/92 (77.17%) previous smears from 79 cases and 17/332 controls (5.12%). The odds ratio (OR) was 63.76 (95% CI 30.57–132.96). Among cases the proportion of HPV-positive smears declined slightly with increasing latency. Among cases, HPV was found in 81.24% (95% CI 69.93–88.96%) of smears with latency < 4 years and in 67.80% (95% CI 47.72–82.93%) of those taken at longer intervals, up to 6 years. These findings suggest that testing for high-risk HPV allows predicting 80% of CINII/III 3 years before the cytological diagnosis and two thirds 6 years before. They also suggest that testing women negative for high-risk HPV at longer interval and strictly following-up women who are HPV positive could be an effective strategy for cervical cancer screening. © 2000 Cancer Research Campaign http://www.bjcancer.com More... »
PAGES1462-1467
http://scigraph.springernature.com/pub.10.1054/bjoc.2000.1491
DOIhttp://dx.doi.org/10.1054/bjoc.2000.1491
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1007954422
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/11076654
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Public Health and Health Services",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Adult",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Case-Control Studies",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Cervical Intraepithelial Neoplasia",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Cervix Uteri",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "DNA, Viral",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Female",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Globins",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Middle Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Papillomaviridae",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Papillomavirus Infections",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Predictive Value of Tests",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Retrospective Studies",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Time Factors",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Tumor Virus Infections",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Uterine Cervical Neoplasms",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Cytology Unit, Centre for Cancer Study and Prevention (CSPO), Firenze, Italy",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Cytology Unit, Centre for Cancer Study and Prevention (CSPO), Firenze, Italy"
],
"type": "Organization"
},
"familyName": "Carozzi",
"givenName": "F",
"id": "sg:person.0673306461.39",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673306461.39"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Cancer Epidemiology Unit, ASL TO1, Centre for Cancer Epidemiology and Prevention (CPO), Torino, Italy",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Cancer Epidemiology Unit, ASL TO1, Centre for Cancer Epidemiology and Prevention (CPO), Torino, Italy"
],
"type": "Organization"
},
"familyName": "Ronco",
"givenName": "G",
"id": "sg:person.01206540103.18",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01206540103.18"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Cytology Unit, Centre for Cancer Study and Prevention (CSPO), Firenze, Italy",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Cytology Unit, Centre for Cancer Study and Prevention (CSPO), Firenze, Italy"
],
"type": "Organization"
},
"familyName": "Confortini",
"givenName": "M",
"id": "sg:person.0667445361.38",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0667445361.38"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Cytology Unit, Centre for Cancer Study and Prevention (CSPO), Firenze, Italy",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Cytology Unit, Centre for Cancer Study and Prevention (CSPO), Firenze, Italy"
],
"type": "Organization"
},
"familyName": "Noferini",
"givenName": "D",
"id": "sg:person.01303355111.07",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01303355111.07"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Cytology Unit, Centre for Cancer Study and Prevention (CSPO), Firenze, Italy",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Cytology Unit, Centre for Cancer Study and Prevention (CSPO), Firenze, Italy"
],
"type": "Organization"
},
"familyName": "Maddau",
"givenName": "C",
"id": "sg:person.01116545420.18",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116545420.18"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Diagnostic Medical Imaging, Centre for Cancer Study and Prevention (CSPO), Florence, Italy",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Department of Diagnostic Medical Imaging, Centre for Cancer Study and Prevention (CSPO), Florence, Italy"
],
"type": "Organization"
},
"familyName": "Ciatto",
"givenName": "S",
"id": "sg:person.01174274056.26",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174274056.26"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Cancer Epidemiology Unit, ASL TO1, Centre for Cancer Epidemiology and Prevention (CPO), Torino, Italy",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Cancer Epidemiology Unit, ASL TO1, Centre for Cancer Epidemiology and Prevention (CPO), Torino, Italy"
],
"type": "Organization"
},
"familyName": "Segnan",
"givenName": "N",
"id": "sg:person.0743542266.47",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0743542266.47"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1038/sj.bjc.6690523",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1041726872",
"https://doi.org/10.1038/sj.bjc.6690523"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/bjc.1989.236",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1022777795",
"https://doi.org/10.1038/bjc.1989.236"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/bjc.1997.440",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1010481383",
"https://doi.org/10.1038/bjc.1997.440"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/bjc.1991.350",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1042218657",
"https://doi.org/10.1038/bjc.1991.350"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/bf00051652",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1032711152",
"https://doi.org/10.1007/bf00051652"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/bjc.1995.347",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1010276001",
"https://doi.org/10.1038/bjc.1995.347"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.bjc.6690730",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1011080887",
"https://doi.org/10.1038/sj.bjc.6690730"
],
"type": "CreativeWork"
}
],
"datePublished": "2000-11-14",
"datePublishedReg": "2000-11-14",
"description": "Human papillomavirus (HPV) testing has been suggested for primary screening of cervical cancer. Prediction of future high-grade cervical lesions is crucial for effectiveness and cost. We performed a case control study in a retrospective cohort of women with at least two cervical smears, all but the last one being negative, from the organized cervical screening programme in Florence, Italy. We searched for high-risk HPV in all previous, archival, smears from cases (new histologically confirmed cervical intraepithelial neoplasia (CIN) grade II or worse) and in one previous smear from each control (last smear cytologically normal, matched by age and interval (latency) from last smear). We applied polymerase chain reaction (PCR), and the b-globin gene was used as a DNA preservation marker. High-risk HPV was identified in 71/92 (77.17%) previous smears from 79 cases and 17/332 controls (5.12%). The odds ratio (OR) was 63.76 (95% CI 30.57\u2013132.96). Among cases the proportion of HPV-positive smears declined slightly with increasing latency. Among cases, HPV was found in 81.24% (95% CI 69.93\u201388.96%) of smears with latency < 4 years and in 67.80% (95% CI 47.72\u201382.93%) of those taken at longer intervals, up to 6 years. These findings suggest that testing for high-risk HPV allows predicting 80% of CINII/III 3 years before the cytological diagnosis and two thirds 6 years before. They also suggest that testing women negative for high-risk HPV at longer interval and strictly following-up women who are HPV positive could be an effective strategy for cervical cancer screening. \u00a9 2000 Cancer Research Campaign http://www.bjcancer.com",
"genre": "article",
"id": "sg:pub.10.1054/bjoc.2000.1491",
"inLanguage": "en",
"isAccessibleForFree": true,
"isPartOf": [
{
"id": "sg:journal.1017082",
"issn": [
"0007-0920",
"1532-1827"
],
"name": "British Journal of Cancer",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "11",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "83"
}
],
"keywords": [
"high-risk HPV",
"previous smears",
"polymerase chain reaction",
"odds ratio",
"high-grade cervical lesions",
"human papillomavirus testing",
"cervical screening programme",
"cervical cancer screening",
"case-control study",
"HPV-positive smears",
"longer intervals",
"retrospective cohort",
"cervical cancer",
"cervical lesions",
"cancer screening",
"cervical smears",
"screening program",
"HPV",
"cytological diagnosis",
"control study",
"smears",
"chain reaction",
"primary screening",
"women",
"years",
"screening",
"effective strategy",
"lesions",
"cohort",
"cancer",
"cases",
"diagnosis",
"interval",
"latency",
"testing",
"control",
"markers",
"proportion",
"findings",
"study",
"genes",
"program",
"b-globin gene",
"strategies",
"effectiveness",
"ratio",
"Italy",
"last one",
"reaction",
"Florence",
"cost",
"one",
"prediction",
"archival"
],
"name": "Prediction of high-grade cervical intraepithelial neoplasia in cytologically normal women by human papillomavirus testing",
"pagination": "1462-1467",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1007954422"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1054/bjoc.2000.1491"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"11076654"
]
}
],
"sameAs": [
"https://doi.org/10.1054/bjoc.2000.1491",
"https://app.dimensions.ai/details/publication/pub.1007954422"
],
"sdDataset": "articles",
"sdDatePublished": "2022-05-20T07:21",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_330.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1054/bjoc.2000.1491"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1054/bjoc.2000.1491'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1054/bjoc.2000.1491'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1054/bjoc.2000.1491'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1054/bjoc.2000.1491'
This table displays all metadata directly associated to this object as RDF triples.
254 TRIPLES
22 PREDICATES
103 URIs
88 LITERALS
23 BLANK NODES